San Diego-primarily based Viking Therapeutics marked by itself as a serious competitor inside the weight loss drug marketplace in February soon after revealing promising details from a mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when specified being a weekly injection and in Mar